Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
002550.SZ Stock Price Chart
Explore Changzhou Qianhong Biopharma CO.,LTD interactive price chart. Choose custom timeframes to analyze 002550.SZ price movements and trends.
002550.SZ Company Profile
Discover essential business fundamentals and corporate details for Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
18 Feb 2011
Employees
979.00
Website
https://www.qhsh.com.cnCEO
Ke Wang
Description
Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.
002550.SZ Financial Timeline
Browse a chronological timeline of Changzhou Qianhong Biopharma CO.,LTD corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 22 Aug 2025
EPS came in at ¥0.08 , while revenue for the quarter reached ¥410.89M , missing expectations by -0.03%.
Dividend declared on 29 May 2025
A dividend of ¥0.12 per share was announced, adjusted to ¥0.12. The dividend was paid on 29 May 2025.
Earnings released on 18 Apr 2025
EPS came in at ¥0.04 , while revenue for the quarter reached ¥318.64M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.13 , while revenue for the quarter reached ¥450.88M .
Earnings released on 17 Oct 2024
EPS came in at ¥0.10 , while revenue for the quarter reached ¥352.01M .
Earnings released on 15 Aug 2024
EPS came in at ¥0.06 , while revenue for the quarter reached ¥387.82M .
Dividend declared on 29 May 2024
A dividend of ¥0.12 per share was announced, adjusted to ¥0.12. The dividend was paid on 29 May 2024.
Earnings released on 26 Apr 2024
EPS came in at ¥0.08 , while revenue for the quarter reached ¥461.10M .
Earnings released on 19 Jan 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥343.01M .
Earnings released on 24 Oct 2023
EPS came in at ¥0.06 , while revenue for the quarter reached ¥409.19M .
Earnings released on 21 Jul 2023
EPS came in at ¥0.03 , while revenue for the quarter reached ¥448.54M .
Dividend declared on 26 May 2023
A dividend of ¥0.12 per share was announced, adjusted to ¥0.12. The dividend was paid on 26 May 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.07 , while revenue for the quarter reached ¥608.22M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.04 , while revenue for the quarter reached ¥654.72M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.05 , while revenue for the quarter reached ¥511.94M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.06 , while revenue for the quarter reached ¥584.67M .
Dividend declared on 25 May 2022
A dividend of ¥0.12 per share was announced, adjusted to ¥0.12. The dividend was paid on 25 May 2022.
Earnings released on 25 Apr 2022
EPS came in at -¥0.01 , while revenue for the quarter reached ¥506.56M , missing expectations by -71.91%.
Earnings released on 31 Mar 2022
EPS came in at ¥0.10 , while revenue for the quarter reached ¥552.22M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.07 , while revenue for the quarter reached ¥495.36M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.03 , while revenue for the quarter reached ¥481.80M .
Dividend declared on 21 May 2021
A dividend of ¥0.12 per share was announced, adjusted to ¥0.12. The dividend was paid on 21 May 2021.
Earnings released on 10 Apr 2021
EPS came in at -¥0.22 , while revenue for the quarter reached ¥504.57M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥391.21M .
Earnings released on 30 Oct 2020
EPS came in at ¥0.07 , while revenue for the quarter reached ¥508.35M .
002550.SZ Stock Performance
Access detailed 002550.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.